Skip to content

Menatetrenone

MUSCULO-SKELETAL SYSTEM

Also known as: Menaquinone 4, vitamin k2, Vitamin MK 4

ATC M05BX08

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Menatetrenone is a drug catalogued in DrugCentral. DrugCentral lists 2 molecular targets, including SNCA and Cruzipain. Recorded indications include Hemorrhagic disease of the newborn due to vitamin K deficiency.

  • Molecular targets: SNCA and Cruzipain (2 listed in DrugCentral).
  • Indications: Hemorrhagic disease of the newborn due to vitamin K deficiency.
  • ATC code: M05BX08 (Other drugs affecting bone structure and mineralization).
  • Molecular formula: C31H40O2; molecular weight 444.66 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Hemorrhagic disease of the newborn due to vitamin K deficiency

Mechanism & targets

Molecular targets (2)

TargetGeneActionActivity
Alpha-synucleinSNCAunknownIC50 4.82
Cruzipain—unknownIC50 4.74

ATC classification

ATC codeTherapeutic hierarchy
M05BX08MUSCULO-SKELETAL SYSTEM › DRUGS FOR TREATMENT OF BONE DISEASES › DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION › Other drugs affecting bone structure and mineralization

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Cerebral haemorrhage85.4
Cerebral infarction78.7
Hepatic function abnormal77.8
Disseminated intravascular coagulation56.9
Platelet count decreased51.4
Brain herniation39.9
Renal impairment37.9
Thalamus haemorrhage37.7
Intraventricular haemorrhage35.3
Altered state of consciousness32.1
Embolic stroke31.7
Upper respiratory tract inflammation29.8

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Menatetrenone is on its molecule page.

Molecular formulaC31H40O2
Molecular weight444.66 g/mol
CAS number863-61-6
InChIKeyDKHGMERMDICWDU-GHDNBGIDSA-N
PubChem CID5282367
CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC1=C(C)C(=O)C2=CC=CC=C2C1=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Menatetrenone used for?

DrugCentral lists the following indications for Menatetrenone: Hemorrhagic disease of the newborn due to vitamin K deficiency.

How does Menatetrenone work?

Its molecular targets in DrugCentral include SNCA and Cruzipain.

What is the chemical formula of Menatetrenone?

Menatetrenone has the molecular formula C31H40O2 and a molecular weight of 444.66 g/mol.

Browse: all drugs starting with M · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets2
Indications1
FormulaC31H40O2
DrugCentral ID1685
Interactive profile